COVID-19 has had a detrimental impact on clinical trials worldwide forcing many studies to either pause or stop entirely. Roche, a pharma multinational wanted to enable fast, time-critical remote consenting for its emergency patients and COVID-19 impacted trials. With help of the eConsent solution, part of TCS ADD platform enabling easy accessibility to consenting at home and facilitating one-click patient transportation. “With the eConsent technology, our studies will seamlessly address the current challenges of providing access to patients. The response received from the sites so far, is truly positive and paves the way for efficiently onboarding eConsent technologies and virtual trials.” – Mandy Sodhi, Clinical Operations Leader, Genentech (Roche).